NeuroproteXeon is a leading company in the Medical Devices and Equipment, Pharmaceuticals, Biotechnology, and Life Sciences sectors, focusing on innovative neuroprotection therapies. Committed to advancing treatments for neurological disorders, NeuroproteXeon leverages cutting-edge research to improve patient outcomes and enhance quality of life.
Specialties
Innovative neuroprotection therapies
Neurological disorder treatments
Cutting-edge research
Medical devices and equipment
Biotechnology solutions
Products & Services
Neuroprotection Therapies
Neurological Disorder Treatments
Medical Devices
Pharmaceuticals
Biotechnology Solutions
Contact Information
No contact information available
Competitors & Similar Companies(7)
Neuroderm
Central District, • Israel
Acorda Therapeutics
New York, • United States
Axovant Gene Therapies
Basel-City, • Switzerland
Cerecor Inc.
Maryland, • United States
Sage Therapeutics
Massachusetts, • United States
Reviva Pharmaceuticals
California, • United States
Biogen
Massachusetts, • United States
News & Media
Search Terms:
neuroprotexeon
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Competitors of NeuroproteXeon are Neuroderm, Acorda Therapeutics, Axovant Gene Therapies, Cerecor Inc., Sage Therapeutics, Reviva Pharmaceuticals, Biogen.
What does NeuroproteXeon do?
NeuroproteXeon is a leading company in the Medical Devices and Equipment, Pharmaceuticals, Biotechnology, and Life Sciences sectors, focusing on innovative neuroprotection therapies. Committed to advancing treatments for neurological disorders, NeuroproteXeon leverages cutting-edge research to improve patient outcomes and enhance quality of life.
What are the social media links of NeuroproteXeon?